Arkolith/Insider Trading/TEVA/Form 4

Fox Christine

EVP, U.S. CommercialTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) · full profile →Form 4 · filed May 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$751K
Net Open-Market Flow
-$751K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 30, 2026Sell(S)21K$35.31$751K64K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-203920) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML